Am J Epidemiol 2002; 156:806-812.
Copyright © 2002 by Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Risk of Gestational Hypertension in Relation to Folic Acid Supplementation during Pregnancy
From the Slone Epidemiology Center, Boston University School of Public Health, Boston, MA.
The authors investigated the association between folic acid supplementation and gestational hypertension. The study population included women with nonmalformed infants in the United States and Canada who were participating in the Slone Epidemiology Center Birth Defects Study between 1993 and 2000. Women were interviewed within 6 months after delivery about sociodemographic and medical factors, the occurrence of hypertension with or without preeclampsia, and multivitamin use in pregnancy. Relative risks, adjusted for weight, parity, twin pregnancy, diabetes, smoking, education, and family income, were estimated using Cox regression models. Of 2,100 women, 204 (9.7%) reported gestational hypertension (onset after the 20th week of gestation). The multivariate-adjusted relative risk of developing gestational hypertension during the month after folic acid supplementation, compared with not using folic acid during that same month, was 0.55 (95% confidence interval: 0.39, 0.79). This finding suggests that folic acid-containing multivitamins may reduce the risk of gestational hypertension.
folic acid; hypertension; pre-eclampsia; pregnancy; vitamins
Abbreviations: Abbreviations: CI, confidence interval; RR, relative risk.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Hernandez-Diaz, S. Toh, and S. Cnattingius Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study BMJ, June 18, 2009; 338(jun18_1): b2255 - b2255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Wen MB PhD, J. Zhou MB MSc, Q. Yang MD PhD, W. Fraser MD MSc, O. Olatunbosun MD, and M. Walker MSc MD Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes Can. Med. Assoc. J., December 2, 2008; 179(12): 1263 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Nilsen, S. E. Vollset, S. A. Rasmussen, P. M. Ueland, and A. K. Daltveit Folic Acid and Multivitamin Supplement Use and Risk of Placental Abruption: A Population-based Registry Study Am. J. Epidemiol., April 1, 2008; 167(7): 867 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M Nilsen, S. E Vollset, H. K Gjessing, P. Magnus, H. M Meltzer, M. Haugen, and P. M Ueland Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian Mother and Child Cohort Study. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1134 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Refsum, E. Nurk, A. D. Smith, P. M. Ueland, C. G. Gjesdal, I. Bjelland, A. Tverdal, G. S. Tell, O. Nygard, and S. E. Vollset The Hordaland Homocysteine Study: A Community-Based Study of Homocysteine, Its Determinants, and Associations with Disease J. Nutr., June 1, 2006; 136(6): 1731S - 1740S. [Abstract] [Full Text] [PDF]
|
|